Lincocin Injection, Solution
NDC Package 0009-0107-04

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Frequently Asked Questions

Package Information

Lincocin (lincomycin hydrochloride) injection is a medication used to treat a wide variety of bacterial infections. This formulation utilizes a injection, solution delivery system. Marketed by Pharmacia & Upjohn Company Llc, this product is identified by NDC 0009-0107 and is authorized under FDA application NDA050317.

Identification & Billing

NDC Package Code
0009-0107-04
Package Description
1 VIAL in 1 CARTON / 10 mL in 1 VIAL
Product Code
0009-0107
11-Digit Billing Format
00009010704
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk
  • RxCUI: 102787 - Lincocin 300 MG/ML Injectable Solution
  • RxCUI: 102787 - lincomycin 300 MG/ML Injectable Solution [Lincocin]
  • RxCUI: 102787 - Lincocin (as lincomycin HCl) 300 MG/ML Injectable Solution
  • RxCUI: 239212 - lincomycin 300 MG/ML Injectable Solution
  • RxCUI: 239212 - lincomycin (as lincomycin HCl) 300 MG/ML Injectable Solution

Clinical Specifications

Proprietary Name
Lincocin
Non-Proprietary Name
Lincomycin Hydrochloride
Substance Name
Lincomycin Hydrochloride
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route
  • Intramuscular - Administration within a muscle.
  • Intravenous - Administration within or into a vein or veins.
  • Subconjunctival - Administration beneath the conjunctiva.
Active Ingredient(s)
LINCOMYCIN HYDROCHLORIDE 300 mg/mL
Usage Information
This medication is used to treat a wide variety of bacterial infections. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

Regulatory & Marketing

Labeler Name
Pharmacia & Upjohn Company Llc
Product Type
Human Prescription Drug
FDA Application #
NDA050317
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
04-18-2023
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Billing & HCPCS Mapping

To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.

J2010
Source: PDAC
INJECTION, LINCOMYCIN HCL, UP TO 300 MG
HCPCS Dosage 300 MG
Units / Pkg

Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0009-0107-04 identifies a specific commercial package of 1 vial in 1 carton / 10 ml in 1 vial of Lincocin, a human prescription drug labeled by Pharmacia & Upjohn Company Llc. This injection, solution is formulated for intramuscular; intravenous; subconjunctival use and contains lincomycin hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Pharmacia & Upjohn Company Llc on April 18, 2023. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used to treat a wide variety of bacterial infections. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

How is this Pharmacia & Upjohn Company Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00009010704. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0009-0107-04
11-Digit CMS (5-4-2)
00009-0107-04

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.